Hybrid Conferencee

International Conference on Cell Signaling and Cancer Therapy (ICCSCT - 26)

16th - 17th October 2026 | Richmond Hill, Canada

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Richmond Hill. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Richmond Hill event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Richmond Hill conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Richmond Hill, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Richmond Hill."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Cancer Cell Biology and Tumor Microenvironment

This track focuses on the intricate biology of cancer cells and their interactions within the tumor microenvironment. It aims to explore the cellular mechanisms that drive tumor progression and metastasis.

Track 02

Diagnostic and Prognostic Biomarkers in Oncology

This session will delve into the latest advancements in the identification and validation of cancer biomarkers for diagnosis and prognosis. Emphasis will be placed on their clinical applications and implications for patient management.

Track 03

Innovations in Cancer Detection and Imaging Technologies

This track will highlight cutting-edge technologies in cancer detection and imaging, including novel imaging modalities and techniques. Discussions will center on their potential to enhance early diagnosis and treatment outcomes.

Track 04

Molecular Mechanisms of Tumor Suppressor Genes

This session will examine the role of tumor suppressor genes in cancer development and progression. Researchers will present findings on the molecular pathways and mechanisms that govern their function.

Track 05

Signal Transduction Pathways in Cancer: Focus on Protein Kinases

This track will investigate the role of protein kinases in cancer-related signal transduction pathways. It will cover their potential as therapeutic targets and the implications for cancer treatment.

Track 06

Role of Steroids and Their Receptors in Cancer Biology

This session will explore the impact of steroids and their receptors on cancer biology and therapy. Discussions will include the mechanisms of action and therapeutic implications of steroid signaling in various cancers.

Track 07

Transgenic Models in Cancer Research

This track will focus on the use of transgenic mouse models to study cancer biology and therapeutic responses. Researchers will share insights into how these models contribute to our understanding of cancer mechanisms.

Track 08

Apoptosis Regulation in Cancer Therapy

This session will address the role of apoptosis in cancer and its regulation as a therapeutic strategy. Presentations will cover novel approaches to modulate apoptotic pathways in cancer treatment.

Track 09

RNA Interference and Its Applications in Cancer Treatment

This track will explore the potential of RNA interference as a therapeutic approach in cancer biology. Discussions will focus on the challenges and successes of implementing RNAi in clinical settings.

Track 10

Carcinogenesis and Mutagenesis: Mechanisms and Implications

This session will investigate the mechanisms of carcinogenesis and mutagenesis, highlighting the genetic and environmental factors involved. It aims to provide insights into prevention strategies and therapeutic interventions.

Track 11

Advancements in Cancer Therapeutics and Drug Development

This track will showcase novel approaches to cancer therapeutics, including drug discovery and development processes. Emphasis will be placed on innovative strategies that enhance treatment efficacy and reduce resistance.